Alaunos Therapeutics, Inc. business relationships
Companies named in Alaunos Therapeutics, Inc.’s 10-K filed 2026-03-31, and public companies whose annual reports name Alaunos Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 22 / 100 Top 5% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Layers: GLP-1 & obesity
Named in Alaunos Therapeutics, Inc.’s annual report 2
“Exclusive License Agreement with Precigen” SEC filing
“In 2015, the Company, Precigen and MD Anderson entered into the 2015 R&D Agreement to formalize the scope and process for the transfer by MD Anderson, pursuant to the terms of the MD Anderson License, of certain existing research programs and related technology rights, as well as the terms and condi...” SEC filing
Companies whose annual reports name Alaunos Therapeutics, Inc. 1
“On April 3, 2023, the Company entered into an amended and restated exclusive license agreement (the "License Agreement"), with Alaunos Therapeutics ("Alaunos").” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.